TrinityPoint Wealth’s Intuitive Surgical ISRG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
$716K Buy
1,371
+253
+23% +$132K 0.1% 188
2024
Q3
$549K Buy
1,118
+6
+0.5% +$2.79K 0.08% 215
2024
Q2
$495K Sell
1,112
-113
-9% -$45K 0.08% 204
2024
Q1
$489K Buy
1,225
+144
+13% +$54.4K 0.08% 200
2023
Q4
$365K Buy
1,081
+191
+21% +$56.9K 0.07% 221
2023
Q3
$260K Buy
890
+28
+3% +$8.74K 0.05% 241
2023
Q2
$295K Buy
862
+8
+0.9% +$2.42K 0.06% 225
2023
Q1
$218K Sell
854
-498
-37% -$123K 0.05% 251
2022
Q4
$359K Buy
+1,352
New +$330K 0.08% 200
2022
Q2
Sell
-1,488
Closed -$449K 294
2022
Q1
$449K Buy
1,488
+131
+10% +$38.3K 0.08% 198
2021
Q4
$488K Buy
1,357
+145
+12% +$49.9K 0.09% 188
2021
Q3
$402K Buy
+1,212
New +$407K 0.08% 206
2020
Q3
Sell
-1,551
Closed -$295K 221
2020
Q2
$295K Buy
+1,551
New +$278K 0.09% 168
2020
Q1
Sell
-1,326
Closed -$261K 202
2019
Q4
$261K Buy
1,326
+111
+9% +$20.8K 0.09% 183
2019
Q3
$227K Buy
+1,215
New +$210K 0.08% 192

Other funds holding ISRG

TrinityPoint Wealth's ISRG Position: Q4 2024 in Review

TrinityPoint Wealth increased its Intuitive Surgical (ISRG) stake by 23% in Q4 2024, buying an estimated $132K and bringing the position to 1,371 shares worth $716K. The position accounts for 0.1% of the portfolio, ranked #188.

TrinityPoint Wealth first reported a position in ISRG in Q3 2019 and has held it in 15 quarters since. 2,129 funds tracked by Wall St. Rank hold ISRG as of Q4 2024.

  • TrinityPoint Wealth held 1,371 shares of Intuitive Surgical worth $716K as of Q4 2024.
  • TrinityPoint Wealth bought 253 Intuitive Surgical shares in Q4 2024, an estimated $132K.
  • Intuitive Surgical made up 0.1% of TrinityPoint Wealth's portfolio in Q4 2024, its #188 holding.
  • TrinityPoint Wealth first reported a position in Intuitive Surgical in Q3 2019 and has held it in 15 quarters since.
  • 2,129 funds tracked by Wall St. Rank held Intuitive Surgical as of Q4 2024.

Based on TrinityPoint Wealth's 13F filing for Q4 2024, filed 14 Feb 2025.